CancerCare Manitoba, located in Winnipeg, Manitoba, Canada is the provincially mandated cancer agency responsible for setting strategic priorities and long-term planning for cancer and blood disorders. CancerCare Manitoba (CCMB) provides clinical services to both children and adults. The cancer services the organization provides to Manitobans include prevention, early detection, multidisciplinary cancer treatment, supportive and end-of-life care. In addition to patient care, CCMB has been given the mandate for a program of research in cancer.
The CancerCare Manitoba Research Institute (the Institute) was unveiled in May 2021 as a department of CCMB. However, the Institute has a long and rich history of research in Manitoba, evolving from its predecessor institutes and dating back to its foundation as a joint venture with The University of Manitoba in 1969 as The Manitoba Institute of Cell Biology. Research disciplines at the Institute range from basic science, preclinical and translational research, clinical trials, health services research, health care informatics, epidemiology and psychosocial oncology research. Working in multi-disciplinary teams of clinicians, scientists, technicians, research nurses, trainees, and bioinformaticians, the Institute brings together diverse skill sets to translate basic science discoveries into improved patient outcomes.
Since CCMB\'s founding, research has been a key mandate of the organization. Today, research continues to be the pillar that drives CCMB\'s pursuit of excellence. As such, the goal of the Institute is to have a positive impact on the lives of cancer patients. Its mission is to gain, through an interdisciplinary program of research and training in the basic and clinical sciences, a better understanding of the nature of cancer and blood disorders.
The Institute is generously funded by a long-standing partnership with the CancerCare Manitoba Foundation, which provides extensive operational, research platform, equipment, education, and training support.
We invite applications for the position of:
Health Services Research Scientist
CancerCare Manitoba Research Institute
5-year Contingent Appointment - possibility of extension
January 1, 2023 - Dec 31, 2027
Competition# 244-22
Job Summary:
This is an exceptional opportunity for a qualified individual to contribute to the ongoing success of the Institute and the Institute\'s strengths in cancer health services research with a focus on cancer-health equity and to participate in interdisciplinary research and collaboration in an environment with complementary and diverse skills. Reporting to the Lead of the Cancer Health Services Research Platform, the successful candidate is expected to conduct innovative health services research focusing on health equity which includes global cancer control. This research will identify and support the most effective ways to organize, manage, and deliver high-quality cancer services for all Manitobans taking into consideration factors that impact health equity, as well as cancer control and care within the global population.
Qualifications:
The ideal candidate will have a PhD in epidemiology, global health, biostatistics, or other health statistics-oriented field with relevant experience conducting health equity and global health cancer health services research. The candidate will have a minimum of five (5) years of experience with strong demonstrated experience (i.e. peer-reviewed publications) in health services research in the health equity and global health. The candidate will undertake research that applies the principles of cancer epidemiology and a health equity lens to health services research in Manitoba and in collaboration with global partners. Candidate must have an excellent research record, as evidenced by quality publications in journals that have a significant scientific impact; the potential to secure competitive extramural peer reviewed grants; a history of mentoring; and a history of effective and productive collaboration.
Required:
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.